Huntington Disease Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Huntington Disease Clinical Trials Market Overview
The Huntington disease clinical trial market research report provides an overview of the Huntington disease clinical trials scenario. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.
Huntington Disease Clinical Trials Market Segmentation by Regions and Countries
The key regions in the Huntington disease clinical trials market are North America, Europe, Asia-Pacific, South & Central America, and the Middle East & Africa. North America dominates the market with more than 40% of clinical trials conducted on Huntington disease, as of February 2023, followed by Europe, and Asia-Pacific respectively.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada and Japan) countries. United Kingdom has the highest proportion of Huntington Disease to Central Nervous System clinical trials as of February 2023.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, Russia has the highest proportion of clinical trials on the Huntington disease to Central Nervous System clinical trials as of February 2023.
Huntington Disease Clinical Trials Analysis by Regions, 2023 (%)
For more regional insights into the Huntington disease clinical trials market, download a free report sample
Huntington disease Clinical Trials Market Segmentation by Sponsor Types
The key sponsor types in the Huntington disease clinical trials market are institution, company, and the government. Out of them, more than 60% of trials have been sponsored by company, followed by institution.
Huntington Disease Clinical Trials Market Analysis by Sponsor Types, 2023 (%)
For more sponsor type insights into the Huntington disease clinical trials market, download a free report sample
Huntington Disease Clinical Trials Market - Competitive Landscape
Some of the leading sponsors in the Huntington disease clinical trials market are Teva Pharmaceutical Industries Ltd, Pfizer Inc, Neurocrine Biosciences Inc, Alterity Therapeutics Ltd, F. Hoffmann-La Roche Ltd, Sage Therapeutics Inc, Ionis Pharmaceuticals Inc, Thermo Fisher Scientific Inc, Wave Life Sciences Ltd, and Novartis AG. Teva Pharmaceutical Industries Ltd has conducted the highest number of Huntington disease clinical trials and is followed by Pfizer Inc and Neurocrine Biosciences Inc.
Huntington Disease Clinical Trials Market Analysis by Sponsors, 2023 (%)
To know more about the leading players in the Huntington disease clinical trials market, download a free report sample
Huntington disease Clinical Trials Market Report Overview
Key Regions | Europe, North America, Asia-Pacific, the Middle East & Africa, and South & Central America |
Key Countries (G7) | United States, United Kingdom, Germany, France, Italy, Canada, and Japan |
Key Countries (E7) | Brazil, Russia, India, China, Mexico, Turkey, and Indonesia |
Key Sponsor Types | Institution, Company, and Government |
Leading Sponsors | Teva Pharmaceutical Industries Ltd, Pfizer Inc, Neurocrine Biosciences Inc, Alterity Therapeutics Ltd, F. Hoffmann-La Roche Ltd, Sage Therapeutics Inc, Ionis Pharmaceuticals Inc, Thermo Fisher Scientific Inc, Wave Life Sciences Ltd, and Novartis AG |
Segments Covered in the Report
Huntington disease Clinical Trials Regional Outlook (2023)
- Asia-Pacific
- North America
- Europe
- Middle East & Africa
- South & Central America
Huntington disease Clinical Trials Sponsor Type Outlook (2023)
- Institution
- Company
- Government
Scope
- The report provides a snapshot of the global clinical trials landscape
- The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and end-point status
- The report reviews the top companies involved and enlists all trials (trial title, phase, and status) pertaining to the company
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with reasons for unaccomplishment
- The report provides enrollment trends for the past five years
- The report provides the latest news for the past three months
Reasons to Buy
- Assists in formulating key business strategies about investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top-level analysis of the Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trial count and enrollment trends by country in the global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional, and country level
Pfizer Inc
Neurocrine Biosciences Inc
Alterity Therapeutics Ltd
F. Hoffmann-La Roche Ltd
Sage Therapeutics Inc
Ionis Pharmaceuticals Inc
Thermo Fisher Scientific Inc
Wave Life Sciences Ltd
Novartis AG
Table of Contents
Table
Figures
Frequently asked questions
-
Which was the leading region in the Huntington disease clinical trials market?
North America dominates the Huntington disease clinical trials market as of February 2023.
-
Which was the leading country in the G7 Huntington disease clinical trials market?
United Kingdom has the highest proportion of Huntington Disease to Central Nervous System clinical trials as of February 2023.
-
Which was the leading country in the E7 Huntington disease clinical trials market?
Russia has the highest proportion of clinical trials on the Huntington disease to Central Nervous System clinical trials as of February 2023.
-
What are the key sponsor types in the Huntington disease clinical trials market?
The key sponsor types in the Huntington disease clinical trials market are institution, company, and the government.
-
Who are the leading sponsors in the Huntington disease clinical trials market?
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.